Cryo-Cell International Statistics
Total Valuation
CCEL has a market cap or net worth of $32.14 million. The enterprise value is $41.52 million.
Important Dates
The last earnings date was Wednesday, October 15, 2025, after market close.
| Earnings Date | Oct 15, 2025 |
| Ex-Dividend Date | May 21, 2025 |
Share Statistics
CCEL has 8.06 million shares outstanding. The number of shares has decreased by -1.39% in one year.
| Current Share Class | 8.06M |
| Shares Outstanding | 8.06M |
| Shares Change (YoY) | -1.39% |
| Shares Change (QoQ) | -0.64% |
| Owned by Insiders (%) | 40.01% |
| Owned by Institutions (%) | 7.20% |
| Float | 4.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.01 |
| Forward PS | 1.04 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.20 |
| P/OCF Ratio | 5.06 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 7.80, with an EV/FCF ratio of 6.71.
| EV / Earnings | n/a |
| EV / Sales | 1.31 |
| EV / EBITDA | 7.80 |
| EV / EBIT | 9.59 |
| EV / FCF | 6.71 |
Financial Position
The company has a current ratio of 0.63
| Current Ratio | 0.63 |
| Quick Ratio | 0.54 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.17 |
| Debt / FCF | 2.04 |
| Interest Coverage | 1.86 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 4.29% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 9.68% |
| Revenue Per Employee | $369,157 |
| Profits Per Employee | -$5,507 |
| Employee Count | 86 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 10.50 |
Taxes
In the past 12 months, CCEL has paid $1.93 million in taxes.
| Income Tax | 1.93M |
| Effective Tax Rate | 132.61% |
Stock Price Statistics
The stock price has decreased by -54.81% in the last 52 weeks. The beta is 0.65, so CCEL's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | -54.81% |
| 50-Day Moving Average | 4.32 |
| 200-Day Moving Average | 5.08 |
| Relative Strength Index (RSI) | 45.99 |
| Average Volume (20 Days) | 3,794 |
Short Selling Information
The latest short interest is 9,453, so 0.12% of the outstanding shares have been sold short.
| Short Interest | 9,453 |
| Short Previous Month | 9,397 |
| Short % of Shares Out | 0.12% |
| Short % of Float | 0.22% |
| Short Ratio (days to cover) | 1.11 |
Income Statement
In the last 12 months, CCEL had revenue of $31.75 million and -$473,567 in losses. Loss per share was -$0.06.
| Revenue | 31.75M |
| Gross Profit | 24.47M |
| Operating Income | 4.33M |
| Pretax Income | 1.45M |
| Net Income | -473,567 |
| EBITDA | 5.32M |
| EBIT | 4.33M |
| Loss Per Share | -$0.06 |
Full Income Statement Balance Sheet
The company has $3.22 million in cash and $12.60 million in debt, giving a net cash position of -$9.38 million or -$1.16 per share.
| Cash & Cash Equivalents | 3.22M |
| Total Debt | 12.60M |
| Net Cash | -9.38M |
| Net Cash Per Share | -$1.16 |
| Equity (Book Value) | -14.83M |
| Book Value Per Share | -1.84 |
| Working Capital | -6.78M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $6.35 million and capital expenditures -$171,597, giving a free cash flow of $6.18 million.
| Operating Cash Flow | 6.35M |
| Capital Expenditures | -171,597 |
| Free Cash Flow | 6.18M |
| FCF Per Share | $0.77 |
Full Cash Flow Statement Margins
Gross margin is 77.07%, with operating and profit margins of 13.64% and -1.49%.
| Gross Margin | 77.07% |
| Operating Margin | 13.64% |
| Pretax Margin | 4.57% |
| Profit Margin | -1.49% |
| EBITDA Margin | 16.76% |
| EBIT Margin | 13.64% |
| FCF Margin | 19.48% |